These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30819408)

  • 1. Methods in pharmacoepidemiology.
    Sommet A; Pariente A
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is pharmacoepidemiology? Definition, methods, interest and clinical applications.
    Montastruc JL; Benevent J; Montastruc F; Bagheri H; Despas F; Lapeyre-Mestre M; Sommet A
    Therapie; 2019 Apr; 74(2):169-174. PubMed ID: 30389102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs.
    Lapeyre-Mestre M; Montastruc F
    Therapie; 2019 Apr; 74(2):209-214. PubMed ID: 30792079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of pharmacoepidemiology in pregnancy-implications for safety.
    Benevent J; Montastruc F; Damase-Michel C
    Expert Opin Drug Saf; 2017 Oct; 16(10):1181-1190. PubMed ID: 28777918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
    ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacoepidemiology in pregnancy.
    Benevent J; Araujo M; Hurault-Delarue C; Montastruc JL; Sommet A; Lacroix I; Damase-Michel C
    Therapie; 2019 Apr; 74(2):289-300. PubMed ID: 30797568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A history of pharmacoepidemiology.
    Bégaud B
    Therapie; 2019 Apr; 74(2):175-179. PubMed ID: 30392701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
    Lapeyre-Mestre M; Sapède C; Moore N; ; Bilbault P; Blin P; Chopy D; Evans D; Gueyffier F; Lacoin L; Malbezin M; Micallef J; Morlet-Vigier D; Muller S; Oger E; Plétan Y; Pons G; Verpillat P; Vigneau C
    Therapie; 2013; 68(4):241-52. PubMed ID: 23981262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoepidemiology and Drug Safety's special issue on validation studies.
    Chun DS; Lund JL; Stürmer T
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):123-125. PubMed ID: 30714240
    [No Abstract]   [Full Text] [Related]  

  • 11. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
    Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics.
    Luo X; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoepidemiology in older people: Purposes and future directions.
    Laroche ML; Sirois C; Reeve E; Gnjidic D; Morin L
    Therapie; 2019 Apr; 74(2):325-332. PubMed ID: 30773343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left truncation results in substantial bias of the relation between time-dependent exposures and adverse events.
    Hazelbag CM; Klungel OH; van Staa TP; de Boer A; Groenwold RH
    Ann Epidemiol; 2015 Aug; 25(8):590-6. PubMed ID: 25935711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoepidemiology and its input to pharmacovigilance.
    Faillie JL; Montastruc F; Montastruc JL; Pariente A
    Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan.
    Ishiguro C; Takeuchi Y; Uyama Y; Tawaragi T
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):854-9. PubMed ID: 27222073
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
    Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of health care databases for pharmacoepidemiology.
    Takahashi Y; Nishida Y; Asai S
    Eur J Clin Pharmacol; 2012 Feb; 68(2):123-9. PubMed ID: 21808989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pragmatic estimates of the proportion of pediatric inpatients exposed to specific medications in the USA.
    Feudtner C; Dai D; Faerber J; Metjian TA; Luan X
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):890-8. PubMed ID: 23704075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.